Theratechnologies Net Income vs Stock Based Compensation Analysis

THTX Stock

USD 3.21 0.01 0.31%

Theratechnologies financial indicator trend analysis is much more than just breaking down Theratechnologies prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Theratechnologies is a good investment. Please check the relationship between Theratechnologies Net Income and its Stock Based Compensation accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.

Net Income vs Stock Based Compensation

Net Income vs Stock Based Compensation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Theratechnologies Net Income account and Stock Based Compensation. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Theratechnologies' Net Income and Stock Based Compensation is -0.41. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Stock Based Compensation in the same time period over historical financial statements of Theratechnologies, assuming nothing else is changed. The correlation between historical values of Theratechnologies' Net Income and Stock Based Compensation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of Theratechnologies are associated (or correlated) with its Stock Based Compensation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Stock Based Compensation has no effect on the direction of Net Income i.e., Theratechnologies' Net Income and Stock Based Compensation go up and down completely randomly.

Correlation Coefficient

-0.41

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Theratechnologies financial statement analysis. It represents the amount of money remaining after all of Theratechnologies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Most indicators from Theratechnologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Theratechnologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.At this time, Theratechnologies' Tax Provision is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to rise to 17.48 in 2025, whereas Selling General Administrative is likely to drop slightly above 9.6 M in 2025.

	2022	2023	2024	2025 (projected)
Total Revenue	81.8M	85.9M	98.7M	103.7M
Depreciation And Amortization	3.3M	2.8M	3.2M	2.6M

Total Revenue Depreciation And Amortization

Theratechnologies fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Other Current Liab	Short Term Investments	Property Plant And Equipment Gross
Total Assets		0.86	0.62	0.01	0.41	0.6	-0.45	0.95	0.77	0.79	-0.13	0.29	0.9	0.55	0.11	0.73	0.72	0.41	-0.22	0.83	0.97	0.29	0.85	0.46	0.53	0.23
Short Long Term Debt Total	0.86		0.76	-0.41	0.5	0.8	-0.69	0.81	0.73	0.5	0.07	0.63	0.76	0.7	0.1	0.76	0.55	0.59	0.01	0.94	0.9	0.45	0.63	0.61	0.24	0.44
Total Current Liabilities	0.62	0.76		-0.58	0.58	0.75	-0.65	0.61	0.49	0.19	0.18	0.7	0.56	0.61	0.45	0.29	0.42	0.6	0.32	0.83	0.7	0.82	0.3	0.79	0.23	0.54
Total Stockholder Equity	0.01	-0.41	-0.58		-0.43	-0.71	0.66	-0.03	-0.03	0.52	-0.29	-0.91	0.03	-0.64	-0.28	-0.27	0.2	-0.69	-0.75	-0.54	-0.13	-0.36	0.29	-0.75	0.31	-0.68
Property Plant And Equipment Net	0.41	0.5	0.58	-0.43		0.59	-0.17	0.57	0.31	0.07	0.05	0.41	0.34	0.33	0.26	0.31	0.47	0.41	0.41	0.57	0.51	0.34	0.15	0.49	0.47	0.89
Net Debt	0.6	0.8	0.75	-0.71	0.59		-0.77	0.63	0.31	0.11	0.12	0.86	0.41	0.87	0.28	0.69	0.36	0.92	0.44	0.9	0.65	0.34	0.3	0.84	0.12	0.68
Retained Earnings	-0.45	-0.69	-0.65	0.66	-0.17	-0.77		-0.34	-0.26	-0.07	-0.15	-0.79	-0.32	-0.68	-0.5	-0.53	-0.24	-0.7	-0.3	-0.74	-0.52	-0.33	-0.14	-0.8	0.2	-0.26
Accounts Payable	0.95	0.81	0.61	-0.03	0.57	0.63	-0.34		0.7	0.74	-0.28	0.26	0.81	0.53	0.09	0.69	0.72	0.43	-0.1	0.81	0.93	0.26	0.81	0.46	0.55	0.37
Cash	0.77	0.73	0.49	-0.03	0.31	0.31	-0.26	0.7		0.55	-0.14	0.24	0.94	0.4	-0.16	0.56	0.34	0.1	-0.13	0.66	0.8	0.3	0.62	0.29	0.36	0.2
Non Current Assets Total	0.79	0.5	0.19	0.52	0.07	0.11	-0.07	0.74	0.55		-0.36	-0.26	0.64	0.07	-0.04	0.42	0.7	-0.11	-0.66	0.37	0.65	0.09	0.89	-0.08	0.44	-0.26
Non Currrent Assets Other	-0.13	0.07	0.18	-0.29	0.05	0.12	-0.15	-0.28	-0.14	-0.36		0.35	-0.05	0.12	0.06	-0.12	-0.16	0.22	0.14	0.05	-0.04	0.32	-0.24	0.13	0.18	0.23
Other Assets	0.29	0.63	0.7	-0.91	0.41	0.86	-0.79	0.26	0.24	-0.26	0.35		0.26	0.86	0.22	0.5	-0.06	0.84	0.64	0.76	0.4	0.4	-0.03	0.85	-0.11	0.66
Cash And Short Term Investments	0.9	0.76	0.56	0.03	0.34	0.41	-0.32	0.81	0.94	0.64	-0.05	0.26		0.48	-0.02	0.63	0.47	0.23	-0.13	0.74	0.9	0.29	0.73	0.4	0.56	0.22
Net Receivables	0.55	0.7	0.61	-0.64	0.33	0.87	-0.68	0.53	0.4	0.07	0.12	0.86	0.48		0.02	0.75	0.02	0.85	0.48	0.84	0.59	0.17	0.33	0.8	0.12	0.54
Common Stock Shares Outstanding	0.11	0.1	0.45	-0.28	0.26	0.28	-0.5	0.09	-0.16	-0.04	0.06	0.22	-0.02	0.02		-0.11	0.4	0.24	0.22	0.23	0.18	0.31	-0.1	0.57	-0.01	0.11
Non Current Liabilities Total	0.73	0.76	0.29	-0.27	0.31	0.69	-0.53	0.69	0.56	0.42	-0.12	0.5	0.63	0.75	-0.11		0.35	0.61	0.03	0.77	0.72	-0.2	0.61	0.49	0.2	0.35
Inventory	0.72	0.55	0.42	0.2	0.47	0.36	-0.24	0.72	0.34	0.7	-0.16	-0.06	0.47	0.02	0.4	0.35		0.2	-0.43	0.48	0.67	0.28	0.63	0.18	0.39	0.12
Other Current Assets	0.41	0.59	0.6	-0.69	0.41	0.92	-0.7	0.43	0.1	-0.11	0.22	0.84	0.23	0.85	0.24	0.61	0.2		0.52	0.75	0.48	0.19	0.11	0.81	0.06	0.62
Other Stockholder Equity	-0.22	0.01	0.32	-0.75	0.41	0.44	-0.3	-0.1	-0.13	-0.66	0.14	0.64	-0.13	0.48	0.22	0.03	-0.43	0.52		0.23	-0.06	0.07	-0.53	0.63	-0.03	0.7
Total Liab	0.83	0.94	0.83	-0.54	0.57	0.9	-0.74	0.81	0.66	0.37	0.05	0.76	0.74	0.84	0.23	0.77	0.48	0.75	0.23		0.88	0.43	0.55	0.81	0.27	0.56
Total Current Assets	0.97	0.9	0.7	-0.13	0.51	0.65	-0.52	0.93	0.8	0.65	-0.04	0.4	0.9	0.59	0.18	0.72	0.67	0.48	-0.06	0.88		0.34	0.74	0.57	0.54	0.37
Short Term Debt	0.29	0.45	0.82	-0.36	0.34	0.34	-0.33	0.26	0.3	0.09	0.32	0.4	0.29	0.17	0.31	-0.2	0.28	0.19	0.07	0.43	0.34		0.1	0.36	0.07	0.25
Intangible Assets	0.85	0.63	0.3	0.29	0.15	0.3	-0.14	0.81	0.62	0.89	-0.24	-0.03	0.73	0.33	-0.1	0.61	0.63	0.11	-0.53	0.55	0.74	0.1		0.12	0.46	-0.09
Other Current Liab	0.46	0.61	0.79	-0.75	0.49	0.84	-0.8	0.46	0.29	-0.08	0.13	0.85	0.4	0.8	0.57	0.49	0.18	0.81	0.63	0.81	0.57	0.36	0.12		0.12	0.6
Short Term Investments	0.53	0.24	0.23	0.31	0.47	0.12	0.2	0.55	0.36	0.44	0.18	-0.11	0.56	0.12	-0.01	0.2	0.39	0.06	-0.03	0.27	0.54	0.07	0.46	0.12		0.33
Property Plant And Equipment Gross	0.23	0.44	0.54	-0.68	0.89	0.68	-0.26	0.37	0.2	-0.26	0.23	0.66	0.22	0.54	0.11	0.35	0.12	0.62	0.7	0.56	0.37	0.25	-0.09	0.6	0.33

Click cells to compare fundamentals

Theratechnologies Account Relationship Matchups

Theratechnologies fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	119.2M	93.3M	77.8M	53.3M	61.3M	65.0M
Short Long Term Debt Total	56.7M	66.7M	59.0M	45.6M	52.4M	38.4M
Total Current Liabilities	45.1M	114.3M	47.3M	36.9M	42.4M	44.5M
Total Stockholder Equity	17.8M	(22.6M)	(20.9M)	(25.3M)	(22.7M)	(21.6M)
Property Plant And Equipment Net	2.9M	3.1M	2.0M	1.3M	1.1M	1.3M
Net Debt	36.3M	42.9M	24.9M	39.7M	45.7M	47.9M
Retained Earnings	(335.2M)	(382.6M)	(408.7M)	(416.9M)	(375.2M)	(356.4M)
Accounts Payable	15.5M	12.9M	7.0M	6.3M	7.3M	6.4M
Cash	20.4M	23.9M	34.1M	5.9M	6.8M	9.2M
Non Current Assets Total	27.3M	19.9M	14.5M	9.4M	8.4M	8.0M
Non Currrent Assets Other	621K	1.8M	(4.6K)	271K	243.9K	231.7K
Cash And Short Term Investments	40.4M	33.1M	40.9M	9.6M	11.1M	20.7M
Net Receivables	9.3M	10.7M	12.8M	15.0M	17.2M	18.1M
Common Stock Shares Outstanding	92.4M	95.3M	73.1M	49.4M	56.8M	53.3M
Liabilities And Stockholders Equity	119.2M	93.3M	77.8M	53.3M	61.3M	65.0M
Non Current Liabilities Total	56.4M	1.6M	51.3M	41.8M	48.0M	50.4M
Inventory	29.1M	19.7M	6.1M	5.3M	6.1M	7.8M
Other Current Assets	13.2M	10.0M	4.0M	14.1M	16.2M	17.0M
Other Stockholder Equity	12.8M	20.9M	23.2M	26.8M	24.1M	22.9M
Total Liab	101.5M	115.8M	98.6M	78.6M	90.4M	94.9M
Total Current Assets	91.9M	73.4M	63.3M	44.0M	50.6M	35.8M
Accumulated Other Comprehensive Income	(44K)	385K	684K	898K	1.0M	1.1M
Short Term Debt	463K	65.3M	7.7M	3.9M	4.5M	8.8M
Intangible Assets	23.8M	15.0M	12.5M	7.6M	8.7M	13.0M
Other Current Liab	29.0M	35.7M	32.6M	26.6M	30.6M	32.1M
Short Term Investments	20.0M	9.2M	6.3M	3.7M	3.4M	3.2M
Property Plant And Equipment Gross	3.6M	3.9M	3.2M	3.5M	3.1M	3.3M
Current Deferred Revenue	70K	50K	54K	38K	34.2K	32.5K
Common Stock	287.3M	335.8M	338.8M	363.9M	418.5M	313.2M
Net Tangible Assets	(14.9M)	(28.6M)	(6.1M)	(37.6M)	(33.8M)	(32.1M)
Long Term Debt	52.4M	54.2M	50.7M	40.9M	47.1M	39.0M
Property Plant Equipment	1.1M	3.5M	2.9M	3.1M	3.6M	3.7M
Net Invested Capital	72.0M	42.2M	37.1M	19.2M	17.2M	16.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
V	Visa Class A
GOOG	Alphabet Inc Class C

Additional Tools for Theratechnologies Stock Analysis

When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Theratechnologies Net Income vs Stock Based Compensation Analysis

Net Income vs Stock Based Compensation

Net Income vs Stock Based Compensation Correlation Analysis

Correlation Coefficient

Net Income

Stock Based Compensation

Theratechnologies fundamental ratios Correlations

Theratechnologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Theratechnologies fundamental ratios Accounts

Also Currently Popular

Additional Tools for Theratechnologies Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 0.97	Total Assets
Accounts Payable	+ 0.95	Total Assets
Total Liab	+ 0.94	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.94	Cash
Total Current Assets	+ 0.93	Accounts Payable
Other Current Assets	+ 0.92	Net Debt

Other Assets	- 0.91	Total Stockholder Equity
Other Current Liab	- 0.8	Retained Earnings
Other Assets	- 0.79	Retained Earnings
Retained Earnings	- 0.77	Net Debt
Other Current Liab	- 0.75	Total Stockholder Equity
Other Stockholder Equity	- 0.75	Total Stockholder Equity